nach oben

Rheumatology International

Erschienen in:

05.07.2019 | Systematic Review

Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis

verfasst von: Lianmin Luo, Qian Xiang, Yihan Deng, Shankun Zhao, Zhiguo Zhu, Yangzhou Liu, Jiamin Wang, Zhigang Zhao

Erschienen in: Rheumatology International | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Previous studies investigating the risk of erectile dysfunction (ED) among patients with gout have produced inconsistent evidence. Therefore, the aim of this meta-analysis was to investigate the relationship between gout and the risk of ED. The Embase, Medline, Scopus, Web of Science and Cochrane Library databases were searched for all studies assessing the risk of ED in patients with gout. Relative risks (RR) and corresponding 95% confidence intervals (CI) were adopted to estimate the association between gout and the risk of ED. Sensitivity analyses were applied to evaluate the robustness of results. Overall, 355,761 participants were included from 8 studies (3 cross-sectional and 5 cohort studies). Of these, 85,067 were patients with gout. Synthesis results showed patients with gout had a 1.2-fold higher risk of ED than individual without gout (RR 1.20, 95% CI 1.10–1.31, P < 0.001). The results of sensitivity analysis are consistent with the trend of synthesis results. The present meta-analysis revealed that the risk of ED in patients with gout was dramatically increased when compared with the general population, which suggests that clinicians should assess erectile function when treating an individual who suffers from gout.

Nur mit Berechtigung zugänglich

Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M (2015) Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 74(4):661–667. https://doi.org/10.1136/annrheumdis-2013-204463 CrossRefPubMed

Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63:3136–3141. https://doi.org/10.1002/art.30520 CrossRefPubMed

Smith E, Hoy D, Cross M et al (2014) The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 73:1470–1476. https://doi.org/10.1136/annrheumdis-2013-204647 CrossRefPubMed

Lee KA, Ryu SR, Park SJ, Kim HR, Lee SH (2018) Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout. Clin Rheumatol 37(5):1351–1358. https://doi.org/10.1007/s10067-017-3963-4 CrossRefPubMed

Thottam GE, Krasnokutsky S, Pillinger MH (2017) Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep 19(10):60. https://doi.org/10.1007/s11926-017-0688-y CrossRefPubMed

Lee J, Lee JY, Lee JH et al (2015) Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study. Arthritis Res Ther 24(17):79. https://doi.org/10.1186/s13075-015-0593-6 CrossRef

Roughley MJ, Belcher J, Mallen CD, Roddy E (2015) Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther 17:90. https://doi.org/10.1186/s13075-015-0610-9 CrossRefPubMedPubMedCentral

Tung YC, Lee SS, Tsai WC et al (2016) Association between gout and incident type 2 diabetes mellitus: a retrospective cohort study. Am J Med 129(11):1219.e17–1219.e25. https://doi.org/10.1016/j.amjmed.2016.06.041 CrossRef

Lin S, Zhang H, Ma A (2018) Association of gout and depression: a systematic review and meta-analysis. Int J Geriatr Psychiatry 33(3):441–448. https://doi.org/10.1002/gps.4789 CrossRefPubMed

10.

Pushkar’ DIu, Kamalov AA, Al’-Shukri SKh et al (2012) Analysis of the results of epidemiological study on prevalence of erectile dysfunction in the Russian Federation. Urologiia 6:5–9

11.

Hatzichristou D, Kirana PS, Banner L et al (2016) Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires. J Sex Med 13:1166–1182. https://doi.org/10.1016/j.jsxm.2016.05.017 CrossRefPubMed

12.

Chen YF, Lin HH, Lu CC et al (2015) Gout and a subsequent increased risk of erectile dysfunction in men aged 64 and under: a nationwide cohort study in Taiwan. J Rheumatol 42(10):1898–1905. https://doi.org/10.3899/jrheum.141105 CrossRefPubMed

13.

Schlesinger N, Radvanski DC, Cheng JQ, Kostis JB (2015) Erectile dysfunction is common among patients with gout. J Rheumatol 42(10):1893–1897. https://doi.org/10.3899/jrheum.141031 CrossRefPubMed

14.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097 CrossRefPubMedPubMedCentral

15.

Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z CrossRefPubMed

16.

Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25. https://doi.org/10.1186/1471-2288-3-25 CrossRefPubMedPubMedCentral

17.

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186 CrossRefPubMed

18.

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRefPubMed

19.

Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629 CrossRefPubMedPubMedCentral

20.

Hsu C-Y, Lin C-L, Kao C-H (2015) Gout is associated with organic and psychogenic erectile dysfunction. Eur J Intern Med 26(9):691–695. https://doi.org/10.1016/j.ejim.2015.06.001 CrossRefPubMed

21.

Kim JH, Chung MK, Kang JY et al (2019) Insulin resistance is an independent predictor of erectile dysfunction in patients with gout. Korean J Intern Med 34(1):202–209. https://doi.org/10.3904/kjim.2016.350 CrossRefPubMed

22.

Roddy E, Muller S, Hayward R, Mallen C (2012) Gout, allopurinol and erectile dysfunction: an epidemiological study in a primary care consultation database. Rheumatology (United Kingdom) 51:iii38

23.

Schlesinger N, Lu N, Choi HK (2018) Gout and the risk of incident erectile dysfunction: a body mass index-matched population-based study. J Rheumatol 45(8):1192–1197. https://doi.org/10.3899/jrheum.170444 CrossRefPubMed

24.

Abdul Sultan A, Mallen C, Hayward R et al (2017) Gout and subsequent erectile dysfunction: a population-based cohort study from England. Arthritis Res Ther 19(1):123. https://doi.org/10.1186/s13075-017-1322-0 CrossRefPubMedPubMedCentral

25.

Maynard JW, McAdams MA, Baer AN et al (2010) Erectile dysfunction is associated with gout in the campaign against cancer and heart disease (CLUE II). Arthritis Rheum 62:1544

26.

Fan D, Liu L, Ding N et al (2015) Male sexual dysfunction and ankylosing spondylitis: a systematic review and meta-analysis. J Rheumatol 42(2):252–257. https://doi.org/10.3899/jrheum.140416 CrossRefPubMed

27.

Keller JJ, Lin HC (2012) A population-based study on the association between rheumatoid arthritis and erectile dysfunction. Ann Rheum Dis 71(6):1102–1103. https://doi.org/10.1136/annrheumdis-2011-200890 CrossRefPubMed

28.

Pluta RM, Shmerling RH, Burke AE, Livingston EH (2012) JAMA patient page. Gout JAMA 308(20):2161. https://doi.org/10.1001/jama.2012.4095 CrossRefPubMed

29.

Robinson PC (2018) Gout—an update of aetiology, genetics, co-morbidities and management. Maturitas 118:67–73. https://doi.org/10.1016/j.maturitas.2018.10.012 CrossRefPubMed

30.

Salem S, Mehrsai A, Heydari R, Pourmand G (2014) Serum uric acid as a risk predictor for erectile dysfunction. J Sex Med 11:1118–1124. https://doi.org/10.1111/jsm.12495 CrossRefPubMed

31.

Long H, Jiang J, Xia J et al (2016) Hyperuricemia is an independent risk factor for erectile dysfunction. J Sex Med 13(7):1056–1062. https://doi.org/10.1016/j.jsxm.2016.04.073 CrossRefPubMed

32.

Lue TF (2000) Erectile dysfunction. N Engl J Med 342:1802–1813. https://doi.org/10.1056/nejm200006153422407 CrossRefPubMed

33.

Kim YW, Park SY, Kim JY et al (2007) Metformin restores the penile expression of nitric oxide synthase in high-fat-fed obese rats. J Androl 28:555–560. https://doi.org/10.2164/jandrol.106.001602 CrossRefPubMed

34.

Abeles AM, Pillinger MH (2019) Gout and cardiovascular disease: crystallized confusion. Curr Opin Rheumatol 31(2):118–124. https://doi.org/10.1097/bor.0000000000000585 CrossRefPubMed

35.

Choi HK, Curhan G (2007) Independent impact of gut on mortality and risk for coronary heart disease. Circulation 116(8):894–900CrossRefPubMed

36.

Pan A, Teng GG, Yuan JM, Koh WP (2015) Bidirectional association between self-reported hypertension and gout: the Singapore Chinese Health Study. PLoS One 10(10):e0141749. https://doi.org/10.1371/journal.pone.0141749 CrossRefPubMedPubMedCentral

37.

Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C (2008) The triad: erectile dysfunction–endothelial dysfunction–cardiovascular disease. Curr Pharm Des 14(35):3700–3714CrossRefPubMed

38.

Kostis JB, Jackson G, Rosen R et al (2005) Sexual dysfunction and cardiac risk (the second princeton consensus conference). Am J Cardiol 96(12B):85M–93M. https://doi.org/10.1016/j.amjcard.2005.12.018 CrossRefPubMed

39.

Blans MC, Visseren FL, Banga JD et al (2006) Infection induced inflammation is associated with erectile dysfunction in men with diabetes. Eur J Clin Investig 36:497–502. https://doi.org/10.1111/j.1365-2362.2006.01653.x CrossRef

40.

Vlachopoulos C, Aznaouridis K, Ioakeimidis N et al (2006) Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 27:2640–2648. https://doi.org/10.1093/eurheartj/ehl341 CrossRefPubMed

41.

Giugliano F, Esposito K, Di Palo C et al (2004) Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Investig 27:665–669. https://doi.org/10.1007/BF03347500 CrossRef

42.

Vanholder R, Patel S, Hsu CH (1993) Effect of uric acid on plasma levels of 1,25(OH)₂D in renal failure. J Am Soc Nephrol 4:1035–1038PubMed

43.

Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J, Higashino K (1998) Decreased serum concentrations of 1,25(OH)₂-vitamin D₃ in patients with gout. Adv Exp Med Biol 431:57–60CrossRefPubMed

44.

Barassi A, Pezzilli R, Colpi GM, Corsi Romanelli MM, Melzi d’Eril GV (2014) Vitamin D and erectile dysfunction. J Sex Med 11:2792–2800. https://doi.org/10.1111/jsm.12661 CrossRefPubMed

45.

Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. Am J Med 125:679–687. https://doi.org/10.1016/j.amjmed.2011.09.033 CrossRefPubMed

46.

Dao HH, Harun-Or-Rashid M, Sakamoto J (2010) Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford) 49:2400–2407. https://doi.org/10.1093/rheumatology/keq274 CrossRef

47.

Besiroglu H, Otunctemur A, Ozbek E (2015) The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies. J Sex Med 12:1309–1318. https://doi.org/10.1111/jsm.12885 CrossRefPubMed

48.

Maseroli E, Corona G, Rastrelli G et al (2015) Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. J Sex Med 12:956–965. https://doi.org/10.1111/jsm.12832 CrossRefPubMed

49.

Liu Q, Zhang Y, Wang J et al (2018) Erectile dysfunction and depression: a systematic review and meta-analysis. J Sex Med 15(8):1073–1082. https://doi.org/10.1016/j.jsxm.2018.05.016 CrossRefPubMed

Titel: Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis
verfasst von: Lianmin Luo
Qian Xiang
Yihan Deng
Shankun Zhao
Zhiguo Zhu
Yangzhou Liu
Jiamin Wang
Zhigang Zhao
Publikationsdatum: 05.07.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 9/2019
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-019-04365-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Leflunomide treatment in juvenile idiopathic arthritis

Comorbidity burden in systemic sclerosis: beyond disease-specific complications

Anterior uveitis in patients with spondyloarthropathies in a single US academic center: a retrospective study

Moderate-to-high intensity exercise with person-centered guidance influences fatigue in older adults with rheumatoid arthritis

Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012–2016

Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin